An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling Warning: BPC 157 is a synthetic peptide and an unapproved drug, often promoted with misleading claims. It is prohibited and on the DoD Prohibited Dietary Supplement Ingredients List. Don't gamble with your Evidence out, ideology in. The FDA's quiet peptide pivot has nothing to do with the data and everything to do with whose side the regulator is choosing. On April 15, 2026, the